| Market Capitalization (Millions $) |
4,210 |
| Shares
Outstanding (Millions) |
137 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
4,654 |
| Net Income (TTM) (Millions $) |
135 |
| Cash Flow (TTM) (Millions $) |
130 |
| Capital Exp. (TTM) (Millions $) |
91 |
Perrigo Company Plc
Perrigo Company PLC is an Irish-based international pharmaceutical and consumer health company that produces a wide range of prescription drugs, generic drugs, and over-the-counter (OTC) consumer healthcare products. The company is headquartered in Dublin, Ireland, and has operations in over 30 countries around the world. Perrigo Company PLC is considered to be one of the largest manufacturers of private label OTC pharmaceutical products in the world.
History
Perrigo Company PLC was first established in 1887 as a small grocery store in Allegan, Michigan. In the early 1900s, the company expanded into the manufacture of prescription drugs and vitamins. In the 1980s, Perrigo began manufacturing private label OTC medications, which became the cornerstone of its business.
In 2013, the company acquired Elan Corporation, a biotechnology company headquartered in Irish. The acquisition allowed Perrigo to move its tax domicile to Ireland, a move that became controversial and absorbed considerable public attention.
Products
Perrigo Company PLC's products are available in various forms, including tablets, capsules, creams, liquids, sprays, and gels. The company produces a wide range of products, including prescription medications, generic drugs, and OTC consumer healthcare products. Some of its most popular brands include Prevacid (a proton pump inhibitor for the treatment of acid reflux), Rogaine (a hair growth stimulant), and Claritin (an allergy medication).
Perrigo also manufactures private label products for retailers and other companies, including Walmarts and Target store brands. Some of the most popular OTC products that the company produces for retailers include pain relievers, cold and cough medications, and vitamins.
Organizational Structure
Perrigo Company PLC's organizational structure consists of several business units, including Consumer Healthcare Americas, Consumer Healthcare International, Rx Pharmaceuticals, and Specialty Science. The Consumer Healthcare Americas unit is responsible for the development, manufacture, and distribution of OTC consumer healthcare products in North and South America. The Consumer Healthcare International unit is responsible for the development, manufacture, and distribution of OTC products in Europe, Australia, and other international markets.
The Rx Pharmaceuticals unit is responsible for the development and manufacture of prescription, generic, and specialty drugs. The Specialty Sciences unit is responsible for the development of over-the-counter and prescription healthcare products for specialty healthcare communities.
Financial Information
Perrigo Company PLC is a publicly traded company listed on the New York Stock Exchange under the symbol "PRGO." As of June 2021, the company had a market cap of approximately $5 billion. In 2020, the company reported revenue of $5.1 billion, with the majority of its revenue coming from its Consumer Healthcare business units. The company's net income in 2020 was $261 million.
Controversies
In recent years, Perrigo Company PLC has been the subject of several controversies related to its products and business practices. Some of the most notable controversies include a recall of its ranitidine product (a medication used to treat GERD and peptic ulcers) due to potential contamination, lawsuits related to the company's pricing practices, and a $1.9 billion tax liability dispute with the Irish government. The company has denied any wrongdoing in each of these cases.
Company Address: The Sharp Building, Dublin 2, 0
Company Phone Number: 7094000 Stock Exchange / Ticker: NYSE PRGO
| PRGO is expected to report next financial results on February 27, 2024. |
|
|
